RuCl2[(R)-xylbinap][(R,R)-dpen]200mg

6-Hepten-1-ol>96.0%(GC)5g

Long working distance plan phase Fluarex contrast 20x/0.45 infinity corrected IOS objective, corrected for 1 mm petri dish thickness

2-{[(4-tert-butylphenyl)sulfonyl]amino}propanoic acid, 95.0%, 500mg

3,5-Dimethyl-4-nitrobenzoic acid, 95.0%, 1g

Putrescine dihydrochloride, min. 97%, for biochemistry, 10 g, glass packaging

1-(3,5-dimethylpiperazin-1-yl)-2,2,2-trifluoroethan-1-imine, 95.0%, 250mg

D-PHE-OBZL HCL, 95.0%, 100g

4-Chloro-6-methoxynicotinic acid, 97%, 100mg

4-Bromo-2,6-dimethylphenylisothiocyanate, 98.0%, 1g

2-Fluoro-3-methylbenzamide, 95+%, 1g

3-Methylbenzylamine, 97.0%, 10g

(S)-2-(2-(DIPHENYLPHOSPHINO)PHENYL)-4-PHENYL-4,5-DIHYDROOXAZOLE, 95%, 10g